The AMPK-HIF-1-P-gp pathway of low-dose berberine can improve DOX sensitivity in drug-resistant breast cancer cells; furthermore, high-dose berberine alone, independently of HIF-1 expression, directly induces apoptosis through the AMPK-p53 pathway [191]. The gene discussed is HIF1A; the disease is breast carcinoma.